Showing results (51-60 of 6,496) with videos related to
Sort By:
Pageof 650
Human Vaccines & Immunotherapeutics|July 12, 2022
Immunogenicity of third dose of anti-SARS-CoV-2 vaccine co-administered with influenza vaccine: An open questionPasquale Stefanizzi, Silvio Tafuri, Francesco Paolo BianchiHuman Vaccines & Immunotherapeutics|July 12, 2022
Evaluating the impact of universal varicella vaccination among preschool-aged children in Qingdao, China: An interrupted time-series analysisZheng Gao, Feng Yang, Fei Qi, et al.Human Vaccines & Immunotherapeutics|May 21, 2019
Updated medical care cost estimates for HPV-associated cancers: implications for cost-effectiveness analyses of HPV vaccination in the United StatesHarrell W Chesson, Elissa Meites, Donatus U Ekwueme, et al.Human Vaccines & Immunotherapeutics|May 25, 2019
Vaccine discussions in pregnancy: interviews with midwives to inform design of an intervention to promote uptake of maternal and childhood vaccinesJessica Kaufman, Katie Attwell, Yvonne Hauck, et al.Human Vaccines & Immunotherapeutics|October 13, 2021
BCG vaccination at birth and COVID-19: a case-control study among U.S. military VeteransMichael N Bates, Timothy J Herron, Sandy J Lwi, et al.Human Vaccines & Immunotherapeutics|October 13, 2021
Tracking the impact of the COVID-19 pandemic on routine infant vaccinations in the Dominican RepublicManuel Colomé-Hidalgo, Juan Donado Campos, Ángel Gil de MiguelHuman Vaccines & Immunotherapeutics|April 13, 2022
Long-Term immunopersistence and safety of the Escherichia coli-produced HPV-16/18 bivalent vaccine in Chinese adolescent girlsXingmei Yao, Wengang He, Xianghong Wu, et al.Human Vaccines & Immunotherapeutics|April 13, 2022
Binding and neutralizing abilities of antibodies towards SARS-CoV-2 S2 domainXingsu Gao, Linlin Fan, Binyang Zheng, et al.Human Vaccines & Immunotherapeutics|April 28, 2022
Preventing invasive meningococcal disease in early infancyJessica Presa, Lidia Serra, Catherine Weil-Olivier, et al.Human Vaccines & Immunotherapeutics|July 19, 2022
Effectiveness, immunogenicity, and safety of the quadrivalent HPV vaccine in women and men aged 27-45 yearsIvette Maldonado, Manuel Plata, Mauricio Gonzalez, et al.Pageof 650